MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%

Sector Heatmap

Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%

IRIX — Iridex Corp

Nasdaq

Iridex Corp

CompareBack to Screener
$0.69
+0.05(+7.28%)
O
0.65
H
0.74
L
0.65
V
136.44K
⏱️ End-of-day dataAs of Oct 5, 2026

Chart

About IRIX

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
SectorNot available
IPO DateFeb 16, 1996
Employees108
Stock ExchangeNasdaq
Ticker SymbolIRIX

Key Financial Statistics

Market Cap$11.30M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.61 - $1.65
52-Week Avg Volume121.3K
VWAP$0.70
Transactions614
Total Recorded Bars7,706 days